2m 2m 2m 2m 2m 2m 2m
ABVC BIOPHARMA (ABVC)
NASDAQ
$1.36+$0.005 (+0.37%)
Price as of Jul 14, 2026 4:06 AM EDT- $35.1MMarket Cap
- -61.54%1-Year Change
- BiotechnologyIndustry
ABVC BIOPHARMA (ABVC)
$1.36+$0.005 (+0.37%)
ABVC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.35 | ||
Change | -$0.16 (-10.60%) | ||
Open | $1.41 | ||
High | $1.49 | ||
Low | $1.22 | ||
Previous Close | $1.51 | ||
Volume | 169,320 | ||
30-Day Average Volume | 224,885 | ||
1-Week Change | -28.95% | ||
1-Month Change | 13.45% | ||
1-Year Change | -61.54% | ||
3-Year Change | -70.00% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 26.0M | ||
Total Assets | $19.7M | ||
Market Cap | $35.1M | ||
Enterprise Value | $35.4M | ||
Period: QTR TTM FY | |||
Revenue | -$1,168.00 | ||
Net Income | -$1.6M | ||
Free Cash Flow | -$894,243.00 | ||
EBIT | -$1.6M | ||
EBITDA | -$1.6M | ||
Net Working Capital | -$4.7M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | -30,342 | ||
P/B | 3 | ||
P/E | -23 | ||
PEG | -0 | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 07/25/2023 | ||
Earnings & Revenue